Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial …

JL Raoul, B Sangro, A Forner, V Mazzaferro… - Cancer treatment …, 2011 - Elsevier
Transarterial chemoembolization (TACE) is considered the gold standard for treating
intermediate-stage hepatocellular carcinoma (HCC). However, intermediate-stage HCC …

A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead

RTP Poon, WK Tso, RWC Pang, KKC Ng, R Woo… - Clinical …, 2007 - Elsevier
Background & Aims: To assess the safety and efficacy of transarterial chemoembolization
(TACE) using doxorubicin-eluting beads (DEB) for hepatocellular carcinoma (HCC) …

Predictors of hepatic decompensation after TACE for hepatocellular carcinoma

MAS Kohla, MIA Zeid, M Al-Warraky… - BMJ Open …, 2015 - bmjopengastro.bmj.com
Aim To study predictive factors for hepatic decompensation after transarterial
chemoembolisation (TACE) for hepatocellular carcinoma (HCC). Methods Between …

Prediction of transarterial chemoembolization (TACE) outcome by pre-and postinterventional 13C-methacetin breath test

K Senk, J Wilcke, M Haimerl, N Verloh… - Clinical …, 2021 - content.iospress.com
METHODS: 20 patients with intermediate-stage hepatocellular carcinoma (HCC) received a
LiMAx test 24 h pre and post TACE. In addition, laboratory values were collected to …

Occupational safety evaluation index-based obstacles prediction for manufacturing industries

S Singh, M Kaur, A Bahl, RS Uppal - Modern Physics Letters B, 2020 - World Scientific
A new safety index known as Occupational Safety Evaluation Index (OSEI) is developed to
evaluate and map the level of workplace safety in medium size iron and steel manufacturing …

[HTML][HTML] Risk factors for liver function deterioration after transarterial chemoembolization refractoriness in Child-Pugh class A hepatocellular carcinoma patients

KH Park, JH Kim, WH Choe, SY Kwon, BC Yoo… - The Korean Journal of …, 2020 - kjg.or.kr
Background/Aims: A switch to systemic therapy, such as sorafenib, should be considered for
hepatocellular carcinoma (HCC) patients refractory to transarterial chemoembolization …

明胶海绵颗粒+ 碘油与单纯碘油化疗栓塞巨块型肝癌的临床研究

邢冬娟, 徐爱民 - 肝胆外科杂志, 2012 - cqvip.com
目的比较明胶海绵颗粒+ 碘化油联合化疗栓塞与单独使用碘化油化疗栓塞治疗巨块型肝细胞癌
的近期疗效. 方法将行介入治疗的巨块型肝癌患者随机分为两组: 明胶海绵颗粒+ …

Assessment and monitoring of liver function by 13C-aminopyrine breath test after selective transarterial chemoembolisation of hepatocellular carcinoma

K Schütte, R Seidensticker, O Milbradt… - Zeitschrift für …, 2015 - thieme-connect.com
Background: Liver function and tumor staging are essential parameters for selection of
treatment modalities in patients with hepatocellular carcinoma (HCC). Transarterial …

原发性巨块型肝癌经动脉大剂量碘化油栓塞的应用分析

王小林, 龚高全, 王建华, 颜志平, 程洁敏, 钱晟, 陈颐 - 复旦学报: 医学版, 2009 - cqvip.com
目的回顾性分析原发性巨块型肝癌经动脉注射25-40mL 碘化油栓塞病例的判断治疗效果及安全
性. 方法47 例原发性巨块型肝癌经动脉注射25~ 40mL 碘化油栓塞, 记录术前肿瘤最大径 …

肝动脉化疗栓塞治疗中碘油用量的现状与研究进展

杨永波, 程红岩 - 介入放射学杂志, 2012 - cqvip.com
肝动脉化疗栓塞治疗中碘油用量的现状与研究进展-[维普官方网站]-www.cqvip.com-维普网 我的
维普 购物车 充值 客服 首页 | 期刊大全 | 文献分类 | 优先出版 | 论文检测 | 论文选题 | 在线分享 …